452 related articles for article (PubMed ID: 15543094)
21. Sudden Infant Death Syndrome: review of implicated genetic factors.
Weese-Mayer DE; Ackerman MJ; Marazita ML; Berry-Kravis EM
Am J Med Genet A; 2007 Apr; 143A(8):771-88. PubMed ID: 17340630
[TBL] [Abstract][Full Text] [Related]
22. Why is smoking a risk factor for sudden infant death syndrome?
Gordon AE; El Ahmer OR; Chan R; Al Madani OM; Braun JM; Weir DM; Busuttil A; Blackwell CC
Child Care Health Dev; 2002 Sep; 28 Suppl 1():23-5. PubMed ID: 12515434
[TBL] [Abstract][Full Text] [Related]
23. Adverse effects of nicotine and interleukin-1beta on autoresuscitation after apnea in piglets: implications for sudden infant death syndrome.
Frøen JF; Akre H; Stray-Pedersen B; Saugstad OD
Pediatrics; 2000 Apr; 105(4):E52. PubMed ID: 10742373
[TBL] [Abstract][Full Text] [Related]
24. The protective effect of immunisation against diphtheria, pertussis and tetanus (DPT) in relation to sudden infant death syndrome.
Essery SD; Raza MW; Zorgani A; MacKenzie DA; James VS; Weir DM; Busuttil A; Hallam N; Blackwell C
FEMS Immunol Med Microbiol; 1999 Aug; 25(1-2):183-92. PubMed ID: 10443507
[TBL] [Abstract][Full Text] [Related]
25. Esophagoprotective activity of angiotensin-(1-7) in experimental model of acute reflux esophagitis. Evidence for the role of nitric oxide, sensory nerves, hypoxia-inducible factor-1alpha and proinflammatory cytokines.
Pawlik MW; Kwiecien S; Pajdo R; Ptak-Belowska A; Brzozowski B; Krzysiek-Maczka G; Strzalka M; Konturek SJ; Brzozowski T
J Physiol Pharmacol; 2014 Dec; 65(6):809-22. PubMed ID: 25554985
[TBL] [Abstract][Full Text] [Related]
26. Bedsharing and maternal smoking in a population-based survey of new mothers.
Lahr MB; Rosenberg KD; Lapidus JA
Pediatrics; 2005 Oct; 116(4):e530-42. PubMed ID: 16199682
[TBL] [Abstract][Full Text] [Related]
27. Evidence for a genetic component in sudden infant death syndrome.
Gordon AE; MacKenzie DA; El Ahmer OR; Al Madani OM; Braun JM; Weir DM; Busuttil A; Blackwell CC
Child Care Health Dev; 2002 Sep; 28 Suppl 1():27-9. PubMed ID: 12515435
[TBL] [Abstract][Full Text] [Related]
28. [Intrauterine hypoxia and sudden infant death syndrome].
Habek D; Habek JC; Jugović D; Salihagić A
Acta Med Croatica; 2002; 56(3):109-18. PubMed ID: 12630342
[TBL] [Abstract][Full Text] [Related]
29. Sudden infant death and liver phosphoenolpyruvate carboxykinase analysis.
Sturner WQ; Susa JB
Forensic Sci Int; 1980; 16(1):19-28. PubMed ID: 7399377
[TBL] [Abstract][Full Text] [Related]
30. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation.
Tóth D; Simon G; Reglődi D
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894743
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia.
Delgado M; Leceta J; Ganea D
J Leukoc Biol; 2003 Jan; 73(1):155-64. PubMed ID: 12525573
[TBL] [Abstract][Full Text] [Related]
32. Fetal heart rates in siblings of infants with sudden infant death syndrome.
Hoppenbrouwers T; Hodgman JE; Harper RM; Sterman MB
Obstet Gynecol; 1981 Sep; 58(3):319-25. PubMed ID: 7266951
[TBL] [Abstract][Full Text] [Related]
33. Association of sudden infant death syndrome with VEGF and IL-6 gene polymorphisms.
Dashash M; Pravica V; Hutchinson IV; Barson AJ; Drucker DB
Hum Immunol; 2006 Aug; 67(8):627-33. PubMed ID: 16916659
[TBL] [Abstract][Full Text] [Related]
34. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: evidence for antecedent hypoxia.
Jones KL; Krous HF; Nadeau J; Blackbourne B; Zielke HR; Gozal D
Pediatrics; 2003 Feb; 111(2):358-63. PubMed ID: 12563064
[TBL] [Abstract][Full Text] [Related]
36. IL-1 gene cluster polymorphisms and sudden infant death syndrome.
Ferrante L; Opdal SH; Vege A; Rognum TO
Hum Immunol; 2010 Apr; 71(4):402-6. PubMed ID: 20080142
[TBL] [Abstract][Full Text] [Related]
37. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors.
Blackwell CC; Moscovis SM; Gordon AE; Al Madani OM; Hall ST; Gleeson M; Scott RJ; Roberts-Thomson J; Weir DM; Busuttil A
J Leukoc Biol; 2005 Dec; 78(6):1242-54. PubMed ID: 16204631
[TBL] [Abstract][Full Text] [Related]
38. Selected hormone levels in victims of the sudden infant death syndrome.
Naeye RL; Fisher R; Rubin HR; Demers LM
Pediatrics; 1980 Jun; 65(6):1134-6. PubMed ID: 6990375
[TBL] [Abstract][Full Text] [Related]
39. Can superantigens trigger sudden infant death?
Lindsay JA; Johnson HM; Wallace FM; Soos JM
Med Hypotheses; 1994 Aug; 43(2):81-5. PubMed ID: 7990743
[TBL] [Abstract][Full Text] [Related]
40. Medial smooth muscle thickness in small pulmonary arteries in sudden infant death syndrome revisited.
Krous HF; Floyd CW; Nadeau JM; Silva PD; Blackbourne BD; Langston C
Pediatr Dev Pathol; 2002; 5(4):375-85. PubMed ID: 12016526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
